GlassScriptPhysician profile
Jessica Simon
NPI 1659651099
$11,826.38
in general payments reported to CMS, 2019-2025
34 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $932 · 2021: $1,426 · 2022: $1,388 · 2023: $1,917 · 2024: $2,265 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,152 · Education: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,152.03 |
| Education | $347.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,254.76 | 2019-2025 | Tremfya |
| Abbvie INC. | $1,854.71 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Novartis Pharmaceuticals Corporation | $1,513.38 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $842.62 | 2019-2025 | Ilumya |
| Pfizer INC. | $783.86 | 2019-2025 | |
| Leo Pharma INC. | $692.84 | 2019-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $543.72 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Dermavant Sciences, INC. | $435.52 | 2022-2024 | Vtama |
| Incyte Corporation | $425.26 | 2021-2025 | Opzelura, Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $364.81 | 2019-2025 | Siliq, Jublia, Arazlo |
| Galderma Laboratories, L.P. | $289.60 | 2020-2025 | Nemluvio, Aklief, Epsolay |
| Regeneron Healthcare Solutions, INC. | $271.85 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $223.05 | 2019-2025 | Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.76 | 2022-2025 | Spevigo |
| Ucb, INC. | $205.15 | 2021-2025 | Bimzelx, Cimzia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $151.50 | 2020-2025 | |
| Arcutis Biotherapeutics, INC. | $141.36 | 2023-2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $94.67 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $90.75 | 2019-2024 | |
| Boston Scientific Corporation | $72.87 | 2022 | |
| Organon LLC | $62.24 | 2025 | Vtama |
| Kyowa Kirin, INC. | $45.41 | 2020-2022 | |
| Epi Health, LLC | $44.16 | 2019-2021 | |
| Dermira, INC. | $43.13 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $37.18 | 2019 | |
| Sandoz INC. | $17.57 | 2024 | Hyrimoz |
| Botanix Sb INC | $17.39 | 2025 | Sofdra |
| Blueprint Medicines Corporation | $16.30 | 2022 | |
| Promius Pharma LLC | $14.69 | 2019 | |
| Mission Pharmacal Company | $14.00 | 2020 | |
| Almirall LLC | $13.95 | 2019 | |
| Merck Sharp & Dohme LLC | $13.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
| Prugen, INC. Pharmaceuticals | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.